Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel ME, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Journal of Nuclear Medicine Society of Nuclear Medicine

Book Volume: 61

Pages Range: 1094-1095

Journal Issue: 8

DOI: 10.2967/jnumed.120.249136

Authors with CRIS profile

Marianne Ellen Pavel Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Involved external institutions

University of California San Francisco (UCSF)

United States (USA) (US) Erasmus University Medical Center (MC)

Netherlands (NL) Memorial Sloan Kettering Cancer Center

United States (USA) (US) Wrocław Medical University / Uniwersytet Medyczny we Wrocławiu

Poland (PL) The University of Melbourne

Australia (AU) Ospedale San Martino (IRCCS AOU)

Italy (IT) Universitätsklinikum Essen

Germany (DE) H. Lee Moffitt Cancer Center & Research Institute

United States (USA) (US) University of California Los Angeles (UCLA)

United States (USA) (US)

How to cite

APA:

Bodei, L., Bergsland, E., de Herder, W.W., Ferone, D., Hicks, R.J., Hope, T.A.,... Herrmann, K. (2020). Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? Journal of Nuclear Medicine, 61(8), 1094-1095. https://doi.org/10.2967/jnumed.120.249136

MLA:

Bodei, Lisa, et al. "Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?" Journal of Nuclear Medicine 61.8 (2020): 1094-1095.

BibTeX: Download